Metsystem ApS
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
ReklamebeskyttetCVR 43 83 36 42AnpartsselskabKøbenhavn NStiftet 2023
The company's object is to engage in research and development relating to the prognosis for the recurrence and/or metastasis of cancer, and the response to therapy through personalized medicine, as well as other activities related thereto.
Oplysningerne er hentet 22. november 2026.